Cargando…
Continuous Intravenous Milrinone Therapy in Pediatric Outpatients
Milrinone is a phosphodiesterase 3 inhibitor with both positive inotropic and vasodilator properties. Administered as a continuous infusion, milrinone is indicated for the short-term treatment of patients with acute decompensated heart failure. Despite limited data supporting long-term milrinone the...
Autores principales: | Curley, Michelle, Liebers, Jill, Maynard, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333726/ https://www.ncbi.nlm.nih.gov/pubmed/28248808 http://dx.doi.org/10.1097/NAN.0000000000000214 |
Ejemplares similares
-
The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
por: Del Rio-Pertuz, Gaspar, et al.
Publicado: (2023) -
Allocation of Pediatric Home Care Nursing Hours: The Minnesota Experience
por: Paitich, Lindsey, et al.
Publicado: (2022) -
Review of Intravenous Lipid Emulsion Therapy
por: Spray, Jeffery W.
Publicado: (2016) -
Early Angiographic Resolution of Cerebral Vasospasm with High Dose Intravenous Milrinone Therapy
por: Zeiler, F. A., et al.
Publicado: (2015) -
Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report
por: Al-Jehani, Hosam, et al.
Publicado: (2019)